Great Things

 

How to Schedule

 

Now Accepting

Credit/Debt Cards

 

Videos

Self Help Videos

PTSD Video


Past Emails

 

 

If you would like an appointment call Stan and Treva Voreyer at (406) 443-6074. You can call them weekends too.

 

Suggestions

Amega Wand

 

 

Can-C is a remarkable breakthrough, an eye-drop that can reverse senile cataracts and help prevent other eye aging disorders

 

(Please use this link to order Can-C as I get a small commission. Thanks, Nick) http://www.antiaging-systems.com/scripts/iasrefer.cgi?SOURCE=WAY1&DESTINATION=canc

 

In the East, particularly in Russia, over the last several years, there has been research into a special analogue of the di-peptide carnosine. This particular form is known as N-acetylcarnosine and it has been proven to be highly effective in the treatment of cataracts.

 

Senile cataract surgery is the most commonly performed surgical operation in the world today. There are 1.35 million eye operations each year in the USA, and while cataract surgery is generally recognised as being one of the safest operations, there is a significant complication rate. For example, in the United States 30% to 50% of all patients having cataract extraction, develop opacification of the posterior lens capsule within two years and require further laser treatment.

 

N-acetylcarnosine eye-drops provide treatment without surgery, and allow the patient to keep their natural lens rather than cope with an artificial one.

 

The statistics in the human trials show that N-acetylcarnosine eye-drops applied for 6-months twice daily into the eye, in patients all suffering from senile cataract, had the following results:

88.9% had an improvement of glare sensitivity.
41.5% had an improvement of the transmissivity of the lens.
90% had an improvement in visual acuity.

 

left eyeright eye

 

The pictures show the treatment of human cataract with the eye drops of 1% Can-C for the period of 5 months. The left image shows the appearance of cataract which resembles a bat in its form and the right image shows that this opacity has disappeared after the cited period after treatment with n-acetylcarnosine is completed. The lens has become clearer.

 

How does N-acetylcarnosine work in the eye:
Cataracts are caused by the hardening and discoloration of the lens due to lifelong cross-linking (glycosylation) of the lens proteins with ascorbate. This persists in the aqueous humor at high concentrations, due to the low availability of natural defenses in the form of anti-oxidants (which decline with advancing age).

 

N-acetylcarnosine delivers L-carnosine into the aqueous humor of the eye (the fluid area surrounding the lens) where it acts as a natural and comprehensive anti-oxidant, protecting structural lens proteins from the free-radical induced oxidation process.

 

Using N-acetylcarnosine Eye-drops:
N-acetylcarnosine eye-drops have been shown to have measurable affects within only 1-month of use. However, it is recommended that for maximum efficacy, that administration be continued for a period not less than 3-5 months. In addition, the drops’ effectiveness is increased the sooner they are used after a cataract is detected.

 

Also, considering that senile cataracts are an on-going aging disorder. N-acetylcarnosine may be required on a regular basis to help maintain the eye's natural anti-oxidant defenses.

 

Additional benefits:
Other than senile cataract, N-acetylcarnosine may have other benefits. Although the information is not yet published, the unique N-acetylcarnosine formula with its added and synergistic lubricants, could also provide beneficial results with the following eye-disorders:

  • Presbyopia.
  • Open-angle primary glaucoma (in combination with beta-blockers).
  • Corneal disorders.
  • Computer vision syndrome.
  • Eye strain.
  • Ocular inflammation.
  • Blurred vision.
  • Dry eye syndrome.
  • Retinal diseases.
  • Vitreous opacities and lesions.
  • Complications of diabetes mellitus and other systemic diseases.
  • Contact lens difficulties, particularly with soft contact lenses. (Not only do the lubricants in the Can-C N-acetylcarnosine eye-drop help to make wearing contact lenses more comfortable, but n-acetylcarnosine is also believed to reduce the build up of lactic acid in the eye, thus enabling the lens to be left safely in the eye for longer).

Can-C is the original, high purity, tested and approved brand. If you want assurances about what will work and what will be safe in your eye to use for months at a time, insist on Can-C eye-drops. Can-C is the brand approved and patented by Innovative Vision Products the inventors of this technology.

 

Further Information:
Dr. Babizhayev explains why other forms of carnosine should not be used in eyes in an interview that can be read by clicking here http://www.antiaging-systems.com/extract/babizhayev.htm


He also elaborates about his discovery and 15-years of research with carnosine. We also recommend reading the latest article about N-acetylcarnosine eye-drops http://www.antiaging-systems.com/extract/nac.htm

 

For more technical information, links and testimonials. Here you can read everything you need to know about Can-C eye-drops. For example, about why only a certain kind of N-acetylcarnosine is safe, and why only certain formulas are efficacious for long-term use, plus much more beside-go to http://www.nacetylcarnosine.com/index.htm for further details.

 

Dosage:
As a preventative measure, two drops into both eyes once a day may be a suitable on-going regime. As for treatment, two drops into the affected twice daily is the ideal regime- there is no benefit in exceeding this dose. It is recommended that occasional use of N-acetylcarnosine eye-drops continue even after the reduction/reversal of the cataract to prevent any re-occurrence.

 

Please use this link to order Can-C as I get a small commission. Thanks, Nick

 

http://www.antiaging-systems.com/scripts/iasrefer.cgi?SOURCE=WAY1&DESTINATION=canc

 

Side effects:
To date, no serious side effects or contraindications have been noted in any of the clinical trials.